Shawn mcCormick insider trades: Inspire Medical Systems (INSP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shawn reports to the SEC
and 1 more company
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | INSP | ↓ Sell | 696 | $45.31 | $32K | Direct | May 11, 2026 (3d) |
| Dec 2, 2025 | INSP | ↓ Sell | 1,200 | $139.00 | $167K | Direct | Dec 4, 2025 (2d) |
| Nov 28, 2025 | INSP | ↓ Sell | 2,000 | $127.48 | $255K | Direct | Dec 1, 2025 (3d) |
| May 2, 2025 | INSP | ↓ Sell | 360 | $160.00 | $58K | Direct | May 5, 2025 (3d) |
| Sep 9, 2024 | INSP | ↓ Sell | 800 | $220.00 | $176K | Direct | Sep 11, 2024 (2d) |
| Jun 7, 2023 | NVRO | ↑ Buy | 7,500 | $22.88 | $172K | Direct | Jun 9, 2023 (2d) |
| May 24, 2021 | NVRO | ↓ Sell | 482 | $149.65 | $72K | Direct | May 26, 2021 (2d) |
| May 21, 2020 | NVRO | ↓ Sell | 1,020 | $126.50 | $129K | Direct | May 26, 2020 (5d) |
| Nov 11, 2019 | NVRO | ↓ Sell | 800 | $104.35 | $83K | Direct | Nov 13, 2019 (2d) |
| May 7, 2018 | INSP | ↑ Buy | 3,000 | $16.00 | $48K | By trust | May 9, 2018 (2d) |
| Jun 3, 2015 | TRNX | ↓ Sell | 3,693 | $26.50 | $98K | Direct | Jun 5, 2015 (2d) |
| Feb 3, 2015 | ENTL | ↑ Buy | 2,941 | $17.00 | $50K | Direct | Feb 4, 2015 (1d) |
| Jun 3, 2014 | TRNX | ↓ Sell | 2,870 | $21.42 | $61K | Direct | Jun 5, 2014 (2d) |
| Jun 3, 2013 | TRNX | ↓ Sell | 1,215 | $15.81 | $19K | Direct | Jun 5, 2013 (2d) |
| Nov 16, 2009 | EVVV | ↓ Sell10b5-1 | 5,430 | $12.16 | $66K | Direct | Nov 17, 2009 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other INSP insiders
Open-market trades in the last 12 months
About Shawn mcCormick's insider trades
Shawn mcCormick is a director at Inspire Medical Systems (INSP). Since Nov 16, 2009, Shawn has reported 3 open-market purchases worth $270K and 12 sales worth $1.2M on SEC Form 4. In the last 12 months: 3 sales ($453K).
1 sale (5% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (43 filings), option exercises (4 filings), shares returned to the company (3 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INSP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.